Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003
Public ClinicalTrials.gov record NCT01856309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (Sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T)
Study identification
- NCT ID
- NCT01856309
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Enrollment
- 1,820 participants
Conditions and interventions
Conditions
Interventions
- Sirukumab 100 mg Drug
- Sirukumab 50 mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 6, 2013
- Primary completion
- Apr 29, 2018
- Completion
- Apr 29, 2018
- Last update posted
- May 5, 2019
2013 – 2018
United States locations
- U.S. sites
- 66
- U.S. states
- 24
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Glendale | Arizona | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Covina | California | — | — |
| Not listed | El Cajon | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Hemet | California | — | — |
| Not listed | Huntington Beach | California | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | La Palma | California | — | — |
| Not listed | Placentia | California | — | — |
| Not listed | Upland | California | — | — |
| Not listed | Victorville | California | — | — |
| Not listed | Whittier | California | — | — |
| Not listed | Hamden | Connecticut | — | — |
| Not listed | Aventura | Florida | — | — |
| Not listed | Boca Raton | Florida | — | — |
| Not listed | Brandon | Florida | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | DeBary | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Palm Harbor | Florida | — | — |
| Not listed | Plantation | Florida | — | — |
| Not listed | Sarasota | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Zephyrhills | Florida | — | — |
| Not listed | Cedar Rapids | Iowa | — | — |
| Not listed | Bowling Green | Kentucky | — | — |
| Not listed | Monroe | Louisiana | — | — |
| Not listed | Cumberland | Maryland | — | — |
| Not listed | Hagerstown | Maryland | — | — |
| Not listed | Wheaton | Maryland | — | — |
| Not listed | Rochester | Minnesota | — | — |
| Not listed | Flowood | Mississippi | — | — |
| Not listed | Springfield | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Freehold | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Middleburg Heights | Ohio | — | — |
| Not listed | Edmond | Oklahoma | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Wyomissing | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Cypress | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Katy | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | Mesquite | Texas | — | — |
| Not listed | Victoria | Texas | — | — |
| Not listed | Beckley | West Virginia | — | — |
| Not listed | Clarksburg | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 131 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01856309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01856309 live on ClinicalTrials.gov.